Big Pharma Split Corp. (PRM.TO)
- Previous Close
11.12 - Open
11.16 - Bid 11.10 x --
- Ask 11.17 x --
- Day's Range
11.16 - 11.44 - 52 Week Range
10.35 - 14.97 - Volume
960 - Avg. Volume
1,353 - Market Cap (intraday)
12.934M - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
11.56 - EPS (TTM)
0.99 - Earnings Date --
- Forward Dividend & Yield 1.24 (10.81%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
--
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRM.TO
View MorePerformance Overview: PRM.TO
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRM.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRM.TO
View MoreValuation Measures
Market Cap
12.93M
Enterprise Value
--
Trailing P/E
11.56
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.20
Price/Book (mrq)
0.82
Enterprise Value/Revenue
5.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.91%
Return on Assets (ttm)
5.57%
Return on Equity (ttm)
-3.65%
Revenue (ttm)
3.01M
Net Income Avi to Common (ttm)
-538.62k
Diluted EPS (ttm)
0.99
Balance Sheet and Cash Flow
Total Cash (mrq)
1.03M
Total Debt/Equity (mrq)
84.58%
Levered Free Cash Flow (ttm)
2.48M